In vitro and in vivo antileishmanial efficacy of a combination therapy of diminazene and artesunate against Leishmania donovani in BALB/c mice
Open Access
- 1 June 2011
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Revista do Instituto de Medicina Tropical de São Paulo
- Vol. 53 (3) , 129-132
Abstract
The in vitro and in vivo activity of diminazene (Dim), artesunate (Art) and combination of Dim and Art (Dim-Art) against Leishmania donovani was compared to reference drug; amphotericin B. IC50 of Dim-Art was found to be 2.28 ± 0.24 µg/mL while those of Dim and Art were 9.16 ± 0.3 µg/mL and 4.64 ± 0.48 µg/mL respectively. The IC50 for Amphot B was 0.16 ± 0.32 µg/mL against stationary-phase promastigotes. In vivo evaluation in the L. donovani BALB/c mice model indicated that treatments with the combined drug therapy at doses of 12.5 mg/kg for 28 consecutive days significantly (p < 0.001) reduced parasite burden in the spleen as compared to the single drug treatments given at the same dosages. Although parasite burden was slightly lower (p < 0.05) in the Amphot B group than in the Dim-Art treatment group, the present study demonstrates the positive advantage and the potential use of the combined therapy of Dim-Art over the constituent drugs, Dim or Art when used alone. Further evaluation is recommended to determine the most efficacious combination ratio of the two compounds.Keywords
All Related Versions
This publication has 12 references indexed in Scilit:
- Antileishmanial High-Throughput Drug Screening Reveals Drug Candidates with New ScaffoldsPLOS Neglected Tropical Diseases, 2010
- Drug Resistance in Visceral LeishmaniasisJournal of Biomedicine and Biotechnology, 2009
- Drug Resistance in LeishmaniasisClinical Microbiology Reviews, 2006
- Efficacy of trypan®: a diminazene based drug as antileishmanial agentActa Tropica, 2004
- Antiparasitic activities of medicinal plants used in Ivory CoastJournal of Ethnopharmacology, 2004
- Leishmaniasis– current chemotherapy and recent advances in the search for novel drugsTrends in Parasitology, 2003
- The immunology of susceptibility and resistance to Leishmania major in miceNature Reviews Immunology, 2002
- Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agendaThe Lancet Infectious Diseases, 2002
- Pharmacokinetics of Artemisinin-Type CompoundsClinical Pharmacokinetics, 2000
- Effect of Berenil on Growth, Mitochondrial DNA and Respiration of Leishmania tarentolae Promastigotes*The Journal of Protozoology, 1977